CCND3 and B-cell non-Hodgkin lymphoma: On the other hand, cyclin D3 seems a promising marker in distinguishing SDRPL from other splenic B-cell lymphomas and leukaemias as it is reported to be exclusively expressed in approximately 70% of SDRPLs [3].